Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FRW50
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,112
Award facts
- Contract value 100% obligated
- $3,111.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count unit dose) valued at $3,111.66 under a firm fixed-price contract. The award, announced on August 6, 2025, with an ultimate completion date of August 7, 2025, represents a non-competitive, non-set-aside delivery order. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support vehicle running through December 2026.
As a major pharmaceutical distributor and established federal vendor, AmerisourceBergen Drug Corp supplies comprehensive medical products to support military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. RINVOQ (upadacitinib) is a prescription medication used in the treatment of rheumatoid arthritis and other inflammatory conditions. The company's federal contract portfolio demonstrates extensive capability in fulfilling pharmaceutical procurement requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FRW50?
SPE2DB25FRW50 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 6, 2025.
How much is contract SPE2DB25FRW50 worth?
The government has obligated $3,112 on SPE2DB25FRW50.
Is contract SPE2DB25FRW50 an order under another contract?
Yes. SPE2DB25FRW50 is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FRW50 competed?
The extent of competition for SPE2DB25FRW50 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award